Laboratorio Kemex – Argentina
A specialized oncology manufacturing base producing injectable, liquid, lyophilized and oral solid dosage forms.
Specialty therapies with an oncology focus
Kemex is an Argentine pharmaceutical company focused on specialty therapies, particularly oncology.
The company produces injectable, liquid, lyophilized and oral solid dosage forms for oncology treatments, and exports across Latin America, Asia and Africa.
Oncology manufacturing expertise
- Oncology injectables
- Lyophilized oncology products
- Oral solid oncology products
- Liquid pharmaceutical products
- Research and development of new products
- Pilot-batch manufacturing
Manufacturing strength meets market development
Kemex provides a specialized oncology manufacturing base that complements Uniphar’s commercial and market-development capabilities.
The partnership creates a platform for evaluating, registering and commercializing selected oncology products across Pakistan and international markets.
Publicly available regulatory and market records show Kemex-associated oncology products including:
- Oxaliplatin
- Other antineoplastic medicines
Specific products offered through Uniphar will be presented separately based on finalized licensing, registration and supply arrangements.
Explore a Partnership
Let’s build the next generation of specialty pharmaceutical opportunities together.